Patients with non-alcoholic fatty liver disease may benefit from increased dietary niacin intake

Combustible cigarette smokers are now more likely to quit if they start on e-cigarettes, a trend not seen a decade ago, according to longitudinal data

Share this article EGRIFTA SV is approved for reducing excess abdominal fat in adult patients with human immunodeficiency virus (HIV) infection and lipodystrophy. Credit: Andrey_Popov/Shutterstock.com.